{"provider_url":"https://hatena.blog","image_url":null,"width":"100%","author_url":"https://blog.hatena.ne.jp/marfan-info/","version":"1.0","blog_title":"\u6d77\u5916\u30de\u30eb\u30d5\u30a1\u30f3\u60c5\u5831 | Global Marfan Updates","categories":["\u30aa\u30f3\u30e9\u30a4\u30f3\u30bb\u30df\u30ca\u30fc","Q & A","\u904b\u52d5"],"provider_name":"Hatena Blog","type":"rich","url":"https://marfan-info.hatenablog.com/entry/2025/03/25/174832","published":"2025-03-25 17:48:32","title":"\u904b\u52d5\u306e\u30e1\u30ea\u30c3\u30c8\u306b\u3064\u3044\u3066","description":"Managing HTAD: Key Insights from the 2024 ESC Guidelines 57:36-59:55 Q: This family has genetic testing and they are in the VUS category, but they have been affected by aortic aneurysm for three generations, having, aortic aneurysm repair and valve replacements. Right now, they feel their cardiologi\u2026","author_name":"marfan-info","blog_url":"https://marfan-info.hatenablog.com/","height":"190","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fmarfan-info.hatenablog.com%2Fentry%2F2025%2F03%2F25%2F174832\" title=\"\u904b\u52d5\u306e\u30e1\u30ea\u30c3\u30c8\u306b\u3064\u3044\u3066 - \u6d77\u5916\u30de\u30eb\u30d5\u30a1\u30f3\u60c5\u5831 | Global Marfan Updates\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>"}